DNTH Price Target Alert: $63.00. Issued by Truist Financial
Source: KlickAnalytics
2026-01-08 08:05:37 ET
Full story available on KlickAnalytics.com
Dianthus Therapeutics Inc.
NASDAQ: DNTH
DNTH Trading
4.58% G/L:
$62.885 Last:
493,029 Volume:
$60.16 Open:
DNTH Latest News
March 09, 2026 07:09:07 am
Dianthus Therapeutics Highlights Recent Business Achievements, Including GO Decision for Phase 3 CAPTIVATE CIDP Trial, and Reports Q4 and FY 2025 Financial Results
March 09, 2026 07:00:00 am
Dianthus Therapeutics Announces Early GO Decision Following Interim Responder Analysis in Phase 3 CAPTIVATE Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
March 08, 2026 05:00:00 pm
Dianthus Therapeutics to Host Conference Call and Webcast to Discuss the Interim Responder Analysis Results of the Phase 3 Captivate Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
March 03, 2026 04:01:00 pm
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DNTH Stock Data
$2,196,597,434
37,892,819
0.47%
33
N/A
Biotechnology & Life Sciences
Healthcare
US
New York
